November 4, 2009
FDA Classifies Synthes' Voluntary Medical Device Recall of Synex II Central Body Components as a Class I Recall

October 21, 2009
Synthes Reports Local Currency Sales Growth of 10.0% for Third Quarter 2009 and Maintains Double-Digit Sales Growth through First Nine Months 2009

September 7, 2009
Synthes Awarded Permanent Injunction and US$ 21 MM in Enhanced Damages, Interest and Costs in ProDisc Patent Case against Medtronic

August 20, 2009
Synthes and Kensey Nash Announce Strategic Agreement for Extracellular Matrix Products

July 29, 2009
Synthes' First Half 2009 Results

June 16, 2009
Synthes Statement Regarding Indictment by U.S. Government

May 5, 2009
Synthes Settles with New Jersey Attorney General and Agrees to Reimburse Investigation Costs of US$ 236,000

April 28, 2009
Synthes Reports 9.6% Sales Growth in Local Currencies (3.1% in US$) for First Quarter 2009

April 23, 2009
Resolutions of the 2009 AGM

February 18, 2009
Synthes 2008: Record Sales of US$ 3,192.5 Million Grew 15.7%, and Record Net Earnings Grew 20.0% (13.4% and 15.7% in local currencies, respectively)